Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–36
Headlines
166
Sources here
3
Companies here
10
Current section Argentina Drug Manufacturers - General news
Latest

finance.yahoo.com Regulatory and legal

Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?

On July 23, Genmab A/S (NASDAQ:GMAB) and AbbVie Inc. (NYSE:ABBV) clarified a key clinical setback regarding their jointly developed T-cell engaging bispecific antibody, epcoritamab (DuoBody-CD3xCD20). The Phase 3 EPCORE DLBCL-1 study evaluated epcoritamab monotherapy against investigator's choice of chemoimmunotherapy in transplant-ineligible adults with relapsed/refractory diffuse large B-cell lymphoma. The clarification confirmed that in the United States, where overall …

Main company 🇦🇷 Argentina
Read at finance.yahoo.com
Sharemaestro market context Trend signal active 52 weeks +44.9% · Next-week setup negative 42.7% ABBV stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Just inNext headlines
finance.yahoo.com Market update Main company 🇦🇷 Argentina

Johnson & Johnson (JNJ)’s $5.5B Talc Settlement: Turning Point or Temporary Relief?

The World Health Organization projects that the share of the world's population aged 60 years and older will almost double from 12% in 2015 to 22% by 2050. The Population Reference Bureau expects the number of Americans aged 65 and older to climb from …

JNJ main company DJNJ3 main company
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇷 Argentina

Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine

Two biopharma giants, Merck & Co., Inc. (NYSE:MRK) and Gilead Sciences, Inc. (NASDAQ:GILD), are proving that in modern drug development, the biggest catalyst isn't always competing head-to-head; it is knowing when to join forces. While both companies reported their first-quarter 2026 earnings earlier this …

GILD main company
Sharemaestro market context Price above Trend Line 52 weeks +35.8% GILD stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Earnings Main company 🇦🇷 Argentina

Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth?

AbbVie Inc. (NYSE:ABBV) reported its first-quarter 2026 financial results, delivering worldwide net revenues of $15.002 billion, an increase of 12.4% on a reported basis (10.3% operationally). The company posted GAAP diluted EPS of $0.39 and adjusted diluted EPS of $2.65, which exceeded internal expectations …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +44.9% · Next-week setup negative 42.7% ABBV stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇷 Argentina

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Product Image (Photo: Bristol Myers Squibb)ZENBEXUS™ (iberdomide) Logo Approval based on EXCALIBER-RRMM results showing ZDd doubled minimal residual disease-negative complete response rates versus daratumumab, bortezomib and dexamethasone (41% vs. 21%) in relapsed or refractory multiple myeloma(1) ZENBEXUS marks the arrival of a new treatment …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +63.0% · Next-week setup positive 55.9% BMY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Main company 🇦🇷 Argentina

Merck (MRK) Stock Fair Value Edges Higher After Analysts Back Pipeline Progress

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Price target commentary for Merck has shifted toward a US$140 to US$155 range, anchored by a modest uplift in fair value from US$132.78 to …

MRK main company
Sharemaestro market context Trend signal active 52 weeks +86.8% MRK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Main company 🇦🇷 Argentina

Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation

Investing.com -- Wolfe Research upgraded two major pharmaceutical companies to Outperform on Thursday, citing stronger growth prospects, attractive valuations and a series of upcoming clinical catalysts. For Biogen, Wolfe raised its rating from Peer Perform and set a $300 price target, arguing that the …

BIIB main company
Sharemaestro market context Trend signal active 52 weeks +86.0% · Next-week setup positive 57.5% BIIB stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Provider-linked mention 🇦🇷 Argentina

MeiraGTx Reports Second Quarter 2026 Financial and Operational Results

MeiraGTx Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 and reported positive three-year data from Phase 1 AQUAx clinical trial evaluating AAV2-hAQP1 for the treatment of moderate to severe grade 2/3 radiation-induced xerostomia Completed the acquisition of all interests and rights to botaretigene sparoparvovec (bota-vec) …

JNJ mentioned
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?

Designed to provide broad exposure to the Large Cap Value segment of the US equity market, the Invesco Dividend Achievers ETF (PFM) is a passively managed exchange traded fund launched on September 15, 2005. The fund is sponsored by Invesco. It has amassed assets …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +109.5% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Capital return Main company 🇦🇷 Argentina

Why Gilead Sciences (GILD) Is Back In The Spotlight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Gilead Sciences (GILD) is back in focus after announcing a collaboration with Nucleai that applies AI powered tissue analytics to its antibody drug conjugate …

GILD main company
Sharemaestro market context Price above Trend Line 52 weeks +35.8% GILD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

Spero Therapeutics Inc (SPRO) (Q2 2026) Earnings Call Highlights: FDA Approval of Utebzi and ...

This article first appeared on GuruFocus. Cash and Cash Equivalents: $50.8 million as of June 30, 2026, excluding net proceeds from the July 2026 royalty financing. Revenue: No revenue for Q2 2026, compared to $14.2 million in Q2 2025, primarily due to prior collaboration …

PFE mentioned
Sharemaestro market context Price above Trend Line 52 weeks +28.5% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates

VALNEVA SE Total product sales of €64.0 million In-line with expectations; full-year guidance of €135 -150 million reaffirmed Solid cash position of €121.5 million as of end June 2026 Reflects disciplined cash management and proceeds from the recent reserved offering1 Restructuring program implemented with …

PFE mentioned
Sharemaestro market context Price above Trend Line 52 weeks +28.5% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇷 Argentina

5 Insightful Analyst Questions From Pfizer’s Q2 Earnings Call

5 Insightful Analyst Questions From Pfizer's Q2 Earnings Call Pfizer's second quarter results reflected stability in its core business despite ongoing challenges in COVID-related product demand. The company's performance was shaped by strong execution in its non-COVID portfolio, with management highlighting robust revenue contributions …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +28.5% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇷 Argentina

5 Insightful Analyst Questions From Merck’s Q2 Earnings Call

5 Insightful Analyst Questions From Merck's Q2 Earnings Call Merck's second quarter was marked by continued sales growth, primarily driven by the strength of its oncology portfolio and contributions from new product launches. Management credited higher demand for KEYTRUDA in both early-stage and metastatic …

MRK main company
Sharemaestro market context Trend signal active 52 weeks +86.8% MRK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

Intuitive Surgical (ISRG) Beats On Q2 As Investors Ask If The Bull Case Is Priced In

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Intuitive Surgical (ISRG) shook investors after reporting strong Q2 2026 revenue and earnings that beat expectations, while revealing slower U.S. procedure growth and …

JNJ mentioned DJNJ3 mentioned
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇦🇷 Argentina

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

MRK mentioned
Sharemaestro market context Trend signal active 52 weeks +86.8% MRK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?

Bristol Myers Squibb BMY is navigating a revenue mix shift as growth products portfolio now assumes a larger role in the business, helping mitigate the impact of declining sales from mature products facing generics. The growth portfolio — including Opdivo, Opdivo Qvantig, Orencia, Yervoy, …

BMY mentioned PFE mentioned MRK mentioned
Sharemaestro market context Trend signal active 52 weeks +63.0% · Next-week setup positive 55.9% BMY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
seekingalpha.com Earnings Provider-linked mention 🇦🇷 Argentina

Tigo Energy downgraded at Roth after weak revenue guidance

[Aerial view of large electrical power plant with many rows of solar photovoltaic panels for producing clean ecological electric energy in morning. Renewable electricity with zero emission concept.] Bilanol/iStock via Getty Images Tigo Energy (TYGO [https://seekingalpha.com/symbol/TYGO]) down 5.2% in Wednesday's trading as Roth Capital …

PFE mentioned
Sharemaestro market context Price above Trend Line 52 weeks +28.5% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Main company 🇦🇷 Argentina

Gilead Sciences (GILD) Expands ADC Research With AI Tissue Analytics

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Gilead Sciences (NasdaqGS:GILD) announced a partnership with Nucleai to use AI-powered tissue analytics in its global antibody drug conjugate programs. The collaboration focuses …

GILD main company
Sharemaestro market context Price above Trend Line 52 weeks +35.8% GILD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇦🇷 Argentina

Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish drugmaker behind Wegovy and Ozempic, fell 2.23% intraday after Berenberg downgraded the stock to Hold from Buy, cutting its Copenhagen target to DKK 305 from DKK 325 and its ADR target to $47 …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +109.5% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Regulatory and legal Main company 🇦🇷 Argentina

Eli Lilly Stock Falls While Retatrutide Lawsuits Expand

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY), the drug giant sitting at the center of the obesity boom, filed six lawsuits against businesses it says are illegally selling retatrutide. The timing is striking. Retatrutide is not approved. It is still in Phase …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +109.5% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

JNJ mentioned DJNJ3 mentioned
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Provider-linked mention 🇦🇷 Argentina

Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Absci (ABSI) is back in focus after releasing early Phase 1 data for its lead antibody ABS-201 and securing a US$40 million investment and development …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +109.5% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Regulatory and legal Main company 🇦🇷 Argentina

Lilly Targets Black-Market Retatrutide Sellers

This article first appeared on GuruFocus. Eli Lilly and Co. (LLY, Financials), the pharmaceutical company behind Zepbound and Foundayo, is stepping up its fight against unauthorized sellers of its experimental obesity drug retatrutide. Warning! GuruFocus has detected 8 Warning Sign with JPM. Is LLY …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +109.5% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Balance sheet Provider-linked mention 🇦🇷 Argentina

The Energy and Pharma Giants Quietly Funding HDV’s 3% Yield, and How Safe Each One Is

Quick Read XOM and JNJ earn 'Very Safe' dividend ratings inside HDV, backed by interest coverage of 56x and 64 consecutive annual raises. AbbVie's Skyrizi and Rinvoq are replacing Humira faster than expected, but Net Debt/EBITDA of 2.3x keeps a watchlist tag on its …

JNJ mentioned ABBV mentioned DJNJ3 mentioned
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇦🇷 Argentina

Johnson & Johnson (JNJ) Advances Seltorexant And Expands Outpatient Cardiac Care

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Johnson & Johnson (NYSE: JNJ) is advancing its novel antidepressant Seltorexant into late stage clinical development for major depressive disorder as a potential rapid …

JNJ main company DJNJ3 main company
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

Novo Nordisk Dips 4% in a Month: How Should Investors Play the Stock?

Novo Nordisk NVO stock has declined 4% over the past month, with the company's second-quarter 2026 results emerging as the primary factor behind the recent weakness. Although NVO beat earnings and revenue estimates, investors remained concerned about underlying growth trends in its core obesity …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +109.5% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Main company 🇦🇷 Argentina

Will Pfizer's Non-COVID Portfolio Drive Its Next Phase of Growth?

Pfizer's PFE business mix has changed significantly over the past few years. During the pandemic, the company became heavily dependent on COVID-19 products, Comirnaty (COVID-19 vaccine) and Paxlovid (oral antiviral). However, the company is gradually diversifying its portfolio through a combination of internal product …

PFE main company LLY mentioned
Sharemaestro market context Price above Trend Line 52 weeks +28.5% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses

Tango Therapeutics TNGX incurred a loss of 37 cents per share in the second quarter of 2026, wider than the Zacks Consensus Estimate of a loss of 31 cents. The company had reported a loss of 35 cents per share in the year-ago quarter. …

GILD mentioned
Sharemaestro market context Price above Trend Line 52 weeks +35.8% GILD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
nasdaq.com Analyst action Provider-linked mention 🇦🇷 Argentina

1 Vanguard ETF That Outperforms the S&P 500 and Still Has Room to Run

Key Points The "Magnificent Seven" stocks account for over 53% of this Vanguard ETF. This has helped the ETF outperform the S&P 500 in 13 of the past 20 years. Sluggish performance among its top 10 holdings has slowed returns this year.10 stocks we …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +109.5% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Provider-linked mention 🇦🇷 Argentina

IBD 50 Stocks To Watch: Obesity Drug Giant Eli Lilly Offers New Buy Point

Obesity-drug giant Eli Lilly stock is approaching a new buy point as the ongoing stock market rally strengthens. Continue Reading

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +109.5% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
seekingalpha.com Market update Provider-linked mention 🇦🇷 Argentina

U.K. regulator reaffirms safety of childhood vaccination

[Syringe drawing liquid medication from medical vial] zhikun sun/iStock via Getty Images Days after President Donald Trump ordered major changes to the U.S. childhood immunization schedule, the U.K. drug regulator on Wednesday reaffirmed the safety of pediatric vaccination, noting it remains one of the …

AZN mentioned PFE mentioned
Sharemaestro market context Price below Trend Line 52 weeks +24.4% AZN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇦🇷 Argentina

Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"

Investing.com -- Oppenheimer upgraded Intuitive Surgical to Outperform from Perform with a $500 price target in a note on Wednesday, arguing the company's strategy of "Crowding Out Competitors" is strategically smart. Analyst Suraj Kalia said the change reflects "a more nuanced risk-reward assessment at …

JNJ mentioned DJNJ3 mentioned
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇦🇷 Argentina

Why Revolution Medicines May Be Big Pharma’s Next Takeover Target

Quick Read RVMD has surged 492% over one year on daraxonrasib's landmark pancreatic cancer data showing 13.2 versus 6.7 months median overall survival. MRK ranks as the most likely acquirer, with Keytruda's patent cliff mounting pressure and CEO Robert Davis pledging to diversify its …

JNJ mentioned PFE mentioned DJNJ3 mentioned
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇦🇷 Argentina

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

JNJ mentioned DJNJ3 mentioned
Sharemaestro market context Trend signal active 52 weeks +78.7% · Next-week setup positive 58.1% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇦🇷 Argentina

The S&P 500 Yield Is the Lowest in History: 5 Members of the Legacy Index Yield 6% or More

Quick Read The S&P 500's combined dividend yield hit a record-low 1.04%, but five index members still deliver dividends of 6% or more, all rated Buy. General Mills (GIS) yields 6.9% at just 10x 2026 earnings, while Verizon (VZ) has raised its dividend for …

PFE mentioned
Sharemaestro market context Price above Trend Line 52 weeks +28.5% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context